Therapy Areas: Allergy
7 July 2020 - - US-based nutraceutical company ChromaDex Corp. (NASDAQ: CDXC) has launched a preclinical study in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), ...
6 July 2020 - - US-based biotechnology company Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has initiated late-stage clinical trials evaluating REGN-COV2, Regeneron's investigational doubl...
6 July 2020 - - The European Commission has granted conditional marketing authorisation for Veklury (remdesivir) as a treatment for SARS-CoV-2 infection, the virus that causes COVID-19, US-based ...
25 June 2020 - - US-based biotechnology company Moderna, Inc. (NASDAQ: MRNA) and US-based delivery technologies, development, and manufacturing solutions provider Catalent, Inc. (NYSE: CTLT) have forg...
24 June 2020 - - The US Food and Drug Administration awarded Fast Track designation to US-based NeuroRx, Inc for the investigation of RLF-100 (Aviptadil) for the treatment of acute lung injury/acute r...
11 June 2020 - - Switzerland-based drug developer Relief Therapeutics Holding AG (SIX: RLF) and its US partner, NeuroRx, Inc. have added Houston Methodist Hospital as a site in their Phase 2 clinical ...
Related Headlines